Bernd Bohrmann

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.

Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.

Journal: Nature neuroscience

Published: October 26, 2018

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation.

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation.

Journal: Theranostics

Published: June 13, 2018

Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2.

Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 05, 2018

Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Journal: Scientific reports

Published: April 05, 2018

Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode.

Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode.

Journal: Cell reports

Published: August 14, 2017

Reproductive and developmental toxicology studies with gantenerumab in PS2APP transgenic mice.

Reproductive and developmental toxicology studies with gantenerumab in PS2APP transgenic mice.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: May 03, 2017

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.

Journal: The Journal of pharmacology and experimental therapeutics

Published: March 24, 2017

HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease Model.

HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease Model.

Journal: EBioMedicine

Published: March 15, 2017

TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.

TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.

Journal: EMBO molecular medicine

Published: July 13, 2016

A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.

A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.

Journal: Brain : a journal of neurology

Published: November 04, 2015

Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice.

Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: August 29, 2014

Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.

Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: August 03, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026